PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Vaxcyte, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$63.68+0.06 (+0.09%)
Close on Oct 19, 2026
- Market cap
- $9.20B
- P/E (TTM)
- –
- Dividend yield
- 0.00%